equal to the monthly premiums that would have been paid on behalf of Executive had such payments commenced on the date of the Qualifying Termination. Notwithstanding the foregoing, the Company may elect that, in lieu of paying or reimbursing the...Severance & Change in Control Agreement • April 10th, 2024 • Arcutis Biotherapeutics, Inc. • Pharmaceutical preparations • California
